Platelet Aggregation in Diabetic Patients With Acute Coronary Syndrome Treated With Different Doses of Aspirin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Diabetes is an important risk factor of coronary atherosclerosis, and it\'s well known that platelets of diabetic patients are hyper reactive and so resistant to common antithrombotic therapy. Moreover, in diabetic patients platelets are characterized by high turnover that is responsible of lack of protection by cardioaspirin at common dosage. The aim of our study is to asses the efficacy of different doses of aspirin in diabetic patients with acute coronary syndrome.
Epistemonikos ID: 99106f38d41aaaa3d723dd674c67a4837ed9992b
First added on: May 10, 2024